Literature DB >> 33078836

Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing.

Dongying Li1, Bridgett Knox1, Binsheng Gong1, Si Chen1, Lei Guo1, Zhichao Liu1, Weida Tong1, Baitang Ning1.   

Abstract

Drug-induced liver injury (DILI) is a leading cause of acute liver failure. Reliable and translational biomarkers are needed for early detection of DILI. microRNAs (miRNAs) have received wide attention as a novel class of potential DILI biomarkers. However, it is unclear how DILI drugs other than acetaminophen may influence miRNA expression or which miRNAs could serve as useful biomarkers in humans. We selected ketoconazole (KCZ), a classic hepatotoxin, to study miRNA biomarkers for DILI as a proof of concept for a workflow that integrated in vivo, in vitro, and bioinformatics analyses. We examined hepatic miRNA expression in KCZ-treated rats at multiple doses and durations using miRNA-sequencing and correlated our results with conventional DILI biomarkers such as liver histology. Significant dysregulation of rno-miR-34a-5p, rno-miR-331-3p, rno-miR-15b-3p, and rno-miR-676 was associated with cytoplasmic vacuolization, a phenotype in rat livers with KCZ-induced injury, which preceded the elevation of serum liver transaminases (ALT and AST). Between rats and humans, miR-34a-5p, miR-331-3p, and miR-15b-3p were evolutionarily conserved with identical sequences, whereas miR-676 showed 73% sequence similarity. Using quantitative PCR, we found that the levels of hsa-miR-34a-5p, hsa-miR-331-3p, and hsa-miR-15b-3p were significantly elevated in the culture media of HepaRG cells treated with 100 µM KCZ (a concentration that induced cytotoxicity). Additionally, we computationally characterized the miRNA candidates for their gene targeting, target functions, and miRNA/target evolutionary conservation. In conclusion, we identified miR-34a-5p, miR-331-3p, and miR-15b-3p as translational biomarker candidates for early detection of KCZ-induced liver injury with a workflow applicable to computational toxicology studies. Published by Oxford University Press on behalf of the Society of Toxicology 2020. This work is written by a US Government employee and is in the public domain in the US.

Entities:  

Keywords:  RNA-seq; biomarker; ketoconazole; liver toxicity; microRNA (miRNA); toxicogenomics

Year:  2021        PMID: 33078836      PMCID: PMC7855383          DOI: 10.1093/toxsci/kfaa162

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  53 in total

Review 1.  Concordance of the toxicity of pharmaceuticals in humans and in animals.

Authors:  H Olson; G Betton; D Robinson; K Thomas; A Monro; G Kolaja; P Lilly; J Sanders; G Sipes; W Bracken; M Dorato; K Van Deun; P Smith; B Berger; A Heller
Journal:  Regul Toxicol Pharmacol       Date:  2000-08       Impact factor: 3.271

Review 2.  Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants.

Authors:  Igor Koturbash; Frederick A Beland; Igor P Pogribny
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-21       Impact factor: 4.481

3.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

4.  Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.

Authors:  Julian Krauskopf; Florian Caiment; Sandra M Claessen; Kent J Johnson; Roscoe L Warner; Shelli J Schomaker; Deborah A Burt; Jiri Aubrecht; Jos C Kleinjans
Journal:  Toxicol Sci       Date:  2014-10-29       Impact factor: 4.849

5.  Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.

Authors:  Qiyu Sun; Jian Li; Boxun Jin; Tiezheng Wang; Jiannan Gu
Journal:  Clin Res Hepatol Gastroenterol       Date:  2019-04-30       Impact factor: 2.947

6.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  miRWalk: An online resource for prediction of microRNA binding sites.

Authors:  Carsten Sticht; Carolina De La Torre; Alisha Parveen; Norbert Gretz
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

9.  Functional omics analyses reveal only minor effects of microRNAs on human somatic stem cell differentiation.

Authors:  Jessica Schira-Heinen; Agathe Czapla; Marion Hendricks; Andreas Kloetgen; Wasco Wruck; James Adjaye; Gesine Kögler; Hans Werner Müller; Kai Stühler; Hans-Ingo Trompeter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

Review 10.  MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans.

Authors:  Robert James Hornby; Philip Starkey Lewis; James Dear; Chris Goldring; B Kevin Park
Journal:  Expert Rev Clin Pharmacol       Date:  2014-04-02       Impact factor: 5.045

View more
  1 in total

1.  Differentially Expressed Extracellular Vesicle, Exosome and Non-Exosome miRNA Profile in High and Low Tick-Resistant Beef Cattle.

Authors:  Pevindu Abeysinghe; Natalie Turner; Hassendrini Peiris; Kanchan Vaswani; Nick Cameron; Nathanael McGhee; Jayden Logan; Murray D Mitchell
Journal:  Front Cell Infect Microbiol       Date:  2021-12-17       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.